We are live on ! Find out more
IIP

Intermede Investment Partners Portfolio holdings

AUM $2.16B
1-Year Est. Return 18.47%
This Fund
S&P 500
This Quarter Est. Return
+0.2%
1 Year Est. Return
+18.47%
3 Year Est. Return
+69.55%
5 Year Est. Return
+72.34%
10 Year Est. Return
+364.13%
AUM
$862M
AUM Growth
+$32.3M
Cap. Flow
+$37.2M
Cap. Flow %
4.32%
Top 10 Hldgs %
49.92%
Holding
30
New
3
Increased
19
Reduced
7
Closed
1

Top Sells

Rank Stock Value
1
EL icon
Estee Lauder
EL
+$26.1M
2
ACN icon
Accenture
ACN
+$16.1M
3
TJX icon
TJX Companies
TJX
+$8.55M
4
SRCL
Stericycle Inc
SRCL
+$8.38M
5
TMO icon
Thermo Fisher Scientific
TMO
+$8.35M

Sector Composition

Rank Sector Weight
1 Healthcare 21.23%
2 Industrials 21.22%
3 Communication Services 16.08%
4 Technology 12.81%
5 Financials 11.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CMCSA icon
1
Comcast
CMCSA
$79.1B
$55.7M 6.46%
1,709,308
+34,624
+2% +$1.08M
GOOG icon
2
Alphabet (Google) Class C
GOOG
$3.9T
$48.8M 5.66%
1,409,640
+28,060
+2% +$1.01M
ANSS
3
DELISTED
Ansys
ANSS
$46.3M 5.37%
510,425
+10,435
+2% +$922K
DLTR icon
4
Dollar Tree
DLTR
$23.1B
$44.9M 5.21%
476,789
+9,370
+2% +$793K
MDT icon
5
Medtronic
MDT
$107B
$42.7M 4.96%
492,663
+9,574
+2% +$774K
MA icon
6
Mastercard
MA
$477B
$40.1M 4.64%
454,827
+8,773
+2% +$838K
BEAV
7
DELISTED
B/E Aerospace Inc
BEAV
$38.3M 4.44%
830,030
+185,903
+29% +$8.88M
HDS
8
DELISTED
HD Supply Holdings, Inc.
HDS
$38.1M 4.42%
1,095,332
+22,179
+2% +$755K
AGN
9
DELISTED
Allergan plc
AGN
$37.8M 4.38%
+163,530
New +$37.7M
BABA icon
10
Alibaba
BABA
$269B
$37.8M 4.38%
474,969
+9,621
+2% +$753K
CME icon
11
CME Group
CME
$92.2B
$35.4M 4.1%
362,949
+7,286
+2% +$689K
LBTYA icon
12
Liberty Global Class A
LBTYA
$3.31B
$31.8M 3.69%
1,094,173
+425,695
+64% +$13.8M
VRSK icon
13
Verisk Analytics
VRSK
$26.4B
$30.4M 3.53%
375,130
+7,535
+2% +$591K
ALLE icon
14
Allegion
ALLE
$13B
$30.4M 3.52%
437,464
+120,365
+38% +$8M
TJX icon
15
TJX Companies
TJX
$170B
$30M 3.48%
776,616
-223,916
-22% -$8.55M
VWR
16
DELISTED
VWR Corporation
VWR
$29.7M 3.45%
1,029,251
+161,986
+19% +$4.54M
SCHW
17
Charles Schwab
SCHW
$177B
$24.6M 2.85%
971,307
+451,688
+87% +$12.8M
TMO icon
18
Thermo Fisher Scientific
TMO
$211B
$23M 2.67%
155,839
-56,570
-27% -$8.35M
AMGN icon
19
Amgen
AMGN
$203B
$22.4M 2.59%
147,059
-52,726
-26% -$8.2M
COO icon
20
Cooper Companies
COO
$13.7B
$22.3M 2.58%
518,772
+10,532
+2% +$421K
CHKP icon
21
Check Point Software Technologies
CHKP
$13.3B
$21.9M 2.54%
274,733
+5,578
+2% +$467K
ACN icon
22
Accenture
ACN
$89.9B
$21.8M 2.52%
191,987
-138,587
-42% -$16.1M
FIS icon
23
Fidelity National Information Services
FIS
$21.5B
$20.5M 2.38%
+278,865
New +$19.6M
ECL icon
24
Ecolab
ECL
$75.6B
$18.9M 2.2%
159,707
+3,235
+2% +$377K
BIIB icon
25
Biogen
BIIB
$29.9B
$18.2M 2.11%
75,263
-12,869
-15% -$3.39M

Similar funds

Intermede Investment Partners's Q2 2016 Portfolio in Review

As of Q2 2016, Intermede Investment Partners held 30 positions worth $862M, up 3.9% from $830M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Intermede Investment Partners deployed $37.2M of net new capital in Q2 2016, opening 3 new positions and adding to 19 existing holdings. Its largest new stake was Allergan plc: 163,530 shares worth $37.8M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Industrials and Communication Services.

On the sell side, the largest reduction was Accenture, an estimated $16.1M trimmed.

  • Intermede Investment Partners's largest Q2 2016 buy was Allergan plc: 163,530 shares worth $37.8M.
  • Intermede Investment Partners added most to Liberty Global Class A in Q2 2016, an estimated $13.8M increase.
  • Intermede Investment Partners's biggest Q2 2016 reduction was Accenture, cutting an estimated $16.1M.
  • Intermede Investment Partners fully exited Estee Lauder in Q2 2016, selling an estimated $26.1M.
  • Intermede Investment Partners's ten largest holdings make up 50% of its $862M portfolio in Q2 2016.
  • Intermede Investment Partners opened 3 new positions and closed 1 in Q2 2016.
  • Intermede Investment Partners's portfolio value rose 3.9% quarter-over-quarter to $862M.

Based on Intermede Investment Partners's 13F filing for Q2 2016, filed 27 Jul 2016.